Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Sunvalleyon Jun 02, 2022 9:21pm
143 Views
Post# 34728263

RE:RE:RE:Back To The Data…Recap

RE:RE:RE:Back To The Data…Recap
Your post makes nothing but total sense ScienceFirst. In my way of thinking the only things that can stand in the way of TLT becoming the new SOC in bladder cancer is big pharma,s clout with politics and money both of which could be formidable opponents. Lets hope that common sense overides the nonsense of power and greed in the health sector. I think back to all of the delays and obstacles that TLT has faced in the past 8 years and cannot help but think that a lot of them were manufactured by nefarious sources to delay or impede the company,s progress. I also believe that finally , the proof is in the pudding and TLT,s  success with this new science cannot be denied any longer and they will prevail.
<< Previous
Bullboard Posts
Next >>